Atherosclerosis and vascular calcification in chronic renal failure

V Campean1, D Neureiter, I Varga

  • 1Department of Pathology, Med. II and Med. IV, University of Erlangen-Nurnberg, Erlangen, Germany.

Insights

Patients with chronic kidney disease face high cardiovascular risks, including increased heart attack rates and mortality. Non-traditional factors like inflammation and oxidative stress contribute significantly to these cardiac complications.

Area of Science:

  • Nephrology
  • Cardiology
  • Vascular Biology

Background:

  • Cardiovascular complications are a leading cause of death in chronic kidney disease (CKD) and end-stage renal failure (ESRF) patients.
  • Uremic patients exhibit a 20-fold higher risk of cardiovascular death compared to the general population, exceeding even that of diabetic patients.
  • High rates of myocardial infarction and increased case fatality are observed in CKD patients, irrespective of diabetes status.

Purpose of the Study:

  • To investigate the significant burden of cardiovascular complications in patients with kidney disease.
  • To explore the roles of both traditional and non-traditional risk factors in the pathogenesis of cardiac issues in renal failure.
  • To highlight the unique aspects of atherosclerosis and arteriosclerosis in the context of renal failure.

Main Methods:

  • Review of autopsy and coronary angiography studies to assess coronary atheroma prevalence.
  • Analysis of clinical and autopsy data on plaque formation and vascular calcification.
  • Examination of the contribution of nonclassical risk factors like microinflammation, hyperphosphatemia, and oxidative stress.

Main Results:

  • Coronary atheroma prevalence is approximately 30% in uremic patients.
  • CKD patients show significantly higher myocardial infarction case fatality rates.
  • Renal failure is associated with increased plaque formation and vascular calcification.
  • Nonclassical risk factors (microinflammation, hyperphosphatemia, oxidative stress) play a crucial role.

Conclusions:

  • Cardiovascular disease is a major, life-threatening issue in CKD and ESRF.
  • Both coronary and non-coronary factors contribute to cardiac complications in renal patients.
  • Understanding nonclassical risk factors is essential for managing cardiovascular health in CKD.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...